共 61 条
- [2] Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial [J]. HEADACHE, 2023, 63 (01): : 79 - 88
- [6] Aurora SK, 2010, CEPHALALGIA, V30, P793, DOI 10.1177/0333102410364676
- [10] Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2 [J]. HEADACHE, 2021, 61 (01): : 125 - 136